No Data
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
12 Health Care Stocks Moving In Tuesday's After-Market Session
H.C. Wainwright Maintains Co-diagnostics(CODX.US) With Hold Rating, Cuts Target Price to $1
HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $1
Co-Diagnostics Analyst Ratings
